AI assistant
STAR COMBO PHARMA LIMITED — Capital/Financing Update 2018
Oct 7, 2018
65746_rns_2018-10-07_eb83db15-2390-46c1-99a0-ae0e5e35e81f.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
8 October 2018 ASX Announcement
==> picture [109 x 44] intentionally omitted <==
• Distributor appointed in Guangdong
Star Combo Pharma Limited (ASX: S66) is pleased to announce the finalisation of its first offline Distributor contract in China.
The new distributor contract for the Province of Guangdong will give the company significant additional channels to market including 173 Pharmacy stores, 3,000 Baby Food stores and 200 Supermarkets.
Star Combo has 7 products that were recently approved by Chinese authorities for offline sale in China.
The new distributor has paid an amount of Yuan 20,000 in advance for the rights and must maintain minimum annual sales of approximately A$600k in the first year and growing annually thereafter.
These distribution arrangements have arisen as a result of the recent opening of the Star Combo China sales office in Chongqing.
The Chinese market is expected to be a key contributor to the future revenue growth of the Company.
For further information: Su Zhang CEO Star Combo Pharma Limited E-mail: [email protected]
Star Combo Pharma Ltd
Tel: +61 2 9756 6555 Add: 171-177 Woodpark Rd Smithfield, NSW 2164 Email: [email protected]